English
Español
Deutsch
Italia
Svenska
Nederlands
Dansk
Participate in a study
Investigators
Careers
Events
0
out of
results
Show More
Solutions
Worldwide Flex FSP
Biostatistics & Programming
Clinical Analytics
Clinical Operations
Data Management
Functional Services
Medical Writing
Oversight Monitoring
Patient Safety
Bioanalytical Lab
Bioanalytical Lab Virtual Tour
Full Services Phase I-IV
Phase I & Clinical Pharmacology Services
Phase II-III Clinical Trials
Phase IIIB-Phase IV Clinical Trials
Transition Studies
Expertise
Oncology
Phase of Development
Early Phase Oncology
Late Phase Oncology
Cancer Indication
Bladder Cancer
Breast Cancer
Head & Neck Cancer
Hematologic Cancer
Lung Cancer
Melanoma & Skin Cancer
Ovarian Cancer
Pancreatic Cancer
Rare Cancer
Drug Modality
Antibody-Drug Conjugates
Immuno-Oncology
Oncology Cell & Gene Therapy
Neuroscience
Alzheimer’s Disease & Dementia
Neurology
Pain
Psychedelics
Psychiatry
Internal Medicine
Autoimmune
Cardiovascular
Endocrine and Metabolic Disease
Hematology
Liver Disease
Rare Nephrology
Respiratory
Rare Disease
Cell & Gene Therapy
Capabilities
CATS
Consulting
Drug Depots
Global Regulatory
Health Equity & Inclusivity
Medical Writing
Pharmacovigilance & Drug Safety Services
Protocol Development & Feasibility
Quality Assurance
Trial Optimization
Clinical Monitoring & Site Management
Data Management
Patient Recruitment
Project Management
Rater Services
Tools & Technologies
Insights
Our Story
About Us
Meet the Team
Newsroom
Contact
Contact Us
Global Reach
Request Proposal
Home
/
Newsroom
/
Press Releases
Press Releases
Our latest company announcements.
Latest Press Releases
September 2, 2026
Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials
May 14, 2026
Worldwide Clinical Trials Strengthens Leadership Team – Demonstrating Global Focus and Deepening Therapeutic Expertise
April 23, 2026
Worldwide Clinical Trials and Medidata Announce Strategic Partnership to Embed Medidata AI Across the Full Trial Life...
February 16, 2026
Worldwide Clinical Trials Completes Acquisition of Catalyst Clinical Research
January 20, 2026
Worldwide Clinical Trials Enters Definitive Agreement to Acquire Catalyst Clinical Research
Learn more about
Worldwide Clinical Trials
Meet us at an event
Schedule a consultation
Request a proposal
Press Releases Archive
September 15, 2025
Worldwide Clinical Trials Appoints Alistair Macdonald as Chief Executive Officer
June 17, 2025
Alzinova selects Worldwide Clinical Trials as CRO partner for Phase 2 study of ALZ-101
May 28, 2025
Worldwide Clinical Trials Appoints Stephen Rayda as Its First-Ever Chief Digital & Information Officer
May 21, 2025
Worldwide Clinical Trials Joins WCG’s Avoca Quality Consortium to Elevate Clinical Trial Quality
April 29, 2025
Exclusive Insights into the Rapidly Evolving Future of GLP-1 Research
April 9, 2025
Worldwide Clinical Trials Adds AI-Driven Capability for Patient-Centric Enhanced Clinical Trial Optimization
December 17, 2024
Worldwide Clinical Trials Appoints Jason Meggs as Chief Financial Officer
October 21, 2024
JP Kotha of Worldwide Clinical Trials to Present on Continuous Improvement Strategies for Bioanalytical Laboratories at AAPS 2024 PharmSci 360 Conference
October 9, 2024
Worldwide Clinical Trials Appoints Kellie MacLeod as Executive Vice President, Global Quality Assurance
Previous